GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dicot AB (GREY:DCOIF) » Definitions » FCF Margin %

Dicot AB (Dicot AB) FCF Margin % : 0.00% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Dicot AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Dicot AB's Free Cash Flow for the three months ended in Mar. 2024 was $-1.47 Mil. Dicot AB's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, Dicot AB's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Dicot AB's current FCF Yield % is -18.90%.

The historical rank and industry rank for Dicot AB's FCF Margin % or its related term are showing as below:


DCOIF's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.475
* Ranked among companies with meaningful FCF Margin % only.


Dicot AB FCF Margin % Historical Data

The historical data trend for Dicot AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dicot AB FCF Margin % Chart

Dicot AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial - - - - -

Dicot AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Dicot AB's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Dicot AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dicot AB's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dicot AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Dicot AB's FCF Margin % falls into.



Dicot AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Dicot AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-4.409/0
= %

Dicot AB's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-1.471/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dicot AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Dicot AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dicot AB (Dicot AB) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 30, Uppsala, SWE, SE 752 37
Dicot AB is engaged in developing drugs against sexual dysfunction in Sweden. Its important products are Libiguin which is used for the treatment of erectile dysfunction and premature ejaculation in men, as well as potentially also for the treatment of decreased lust.

Dicot AB (Dicot AB) Headlines

No Headlines